Haiti

Resilience System


You are here

Vaccinations

Pfizer to study using booster shot aimed at virus variant

Pfizer and its partner BioNTech said Thursday they are beginning a study to test whether a third shot of their COVID-19 vaccine will help protect against variants of the virus.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS of the difficulties in comparing vaccines

Yusuff Adebayo Adebisi knows that a vaccine that offers 70% protection against COVID-19 could be a valuable tool against the coronavirus pandemic in Nigeria — especially if that vaccine is cheap and doesn’t have to be stored at extremely cold temperatures. But what if another vaccine — one that is more expensive to buy and to store — was 95% effective?

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

NIH to launch research into Covid long term effects, plus international roundup

Roundup:  NIH to study ‘long-haul’ virus symptoms

  WASHINGTON  (AP) — The National Institutes of Health is launching research to understand the causes and consequences of the lingering brain fog, breathing problems and malaise reported by many recovering COVID-19 patients.

Dr. Anthony Fauci says some studies have shown up to 30% of patients report symptoms that can endure for months, complicating their return to normal routines and work, and plunging many recovering patients into depression.

Fauci noted at a White House coronavirus briefing on Wednesday that work at NIH started this week thanks to more than $1 billion provided by Congress for COVID-related medical research. Government scientists are looking to enlist doctors and research institutions around the country in the effort to learn about “long-haul” COVID-19.

Problem, Solution, SitRep, or ?: 

FDA says Johnson and Johnson vaccine provides protection against Covid, a step toward final decision

FDA says J&J 1-dose shot prevents COVID; final decision soon

WASHINGTON (AP) — Johnson & Johnson’s single-dose vaccine protects against COVID-19, according to an analysis by U.S. regulators Wednesday that sets the stage for a final decision on a new and easier-to-use shot to help tame the pandemic.

The Food and Drug Administration’s scientists confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19. The agency also said J&J’s shot — one that could help speed vaccinations by requiring just one dose instead of two — is safe to use.

That’s just one step in the FDA’s evaluation of a third vaccine option for the U.S. On Friday, the agency’s independent advisers will debate if the evidence is strong enough to recommend the long-anticipated shot. Armed with that advice, FDA is expected to make a final decision within days. ...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Institutional investors urge a more ‘fair and equitable’ international Covid-19 response

Nearly 150 institutional investors that oversee combined assets worth more than $14 trillion have issued a joint call for a “fair and equitable” global response to the Covid-19 pandemic, and they intend to huddle with health care companies to make progress on that goal.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

OVERVIEW: U.S. and International

 
 

SACRAMENTO, Calif. -- California lawmakers have cleared the way for 5.7 million people to get at least $600 in one-time payments, part of a state-sized coronavirus relief package aimed at helping lower-income people weather what they hope is the last legs of the pandemic.

The state Legislature passed the bill by a wide margin on Monday...

BUDAPEST — Officials in Hungary are urging people to trust in the vaccines already approved by the country ahead of a planned rollout Wednesday of a COVID-19 vaccine developed in China.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Vaccinations
howdy folks
Page loaded in 0.933 seconds.